Tag : Biopharmaceutical

AI/ML

Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review.

Newsemia
Related Articles Technology outlook for real-time quality attribute and process parameter monitoring in biopharmaceutical development-A review. Biotechnol Bioeng. 2020 Oct;117(10):3182-3198 Authors: Wasalathanthri DP, Rehmann MS,...
Latest News

AstraZeneca COVID-19 vaccine trial paused due to suspected adverse reaction

Newsemia
The coronavirus disease (COVID-19) pandemic is rippling across the globe, with over 27.47 million reported cases. With the vast spread of the virus, scientists are...
Latest News

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

Newsemia
In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity...
Biology

Study Finds Pandemic Likely to Negatively Impact Biopharmaceutical Sector

Newsemia
BOSTON (PRWEB) May 21, 2020 Threats to intellectual property, political pressure to lower prices, disruption of clinical trials will cause long-term harm Contrary to conventional...
Latest News

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Newsemia
As the world continues to grapple with the coronavirus pandemic, many scientists, institutions, and pharmaceutical companies are working hard to develop an effective vaccine. Source...
Latest News

Avantor launches new Protein A Chromatography Resin – PROchievA – that provides supply chain flexibility and improves downstream purification performance for monoclonal antibodies (mAbs) production

Newsemia
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced...
Latest News

Beijing Tide Pharmaceutical and Insilico Medicine announce cancer drug discovery collaboration

Newsemia
Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines, announced today...
Latest News

Sartorius launches BioPAT Spectro for use with ambr systems and BIOSTAT STR

Newsemia
Sartorius, a leading international partner of the biopharmaceutical industry today introduced BioPAT Spectro, a Quality by Design tool for use with its ambr automated micro...
Latest News

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

Newsemia
Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for...
Latest News

Samenvatting: Abzena organiseert op 19 februari 2020 het tweede Biopharmaceutical Discovery and Development Symposium in Cambridge, Verenigd Koninkrijk

Newsemia
CAMBRIDGE, Engeland–(BUSINESS WIRE)–Abzena, de wereldwijde biologische target-to-GMP Partner Research Organization, maakt vandaag bekend dat het de tweede Biopharmaceutical Discovery and Development Symposium organiseert op de...
Latest News

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Newsemia
Entos Pharmaceuticals Inc. (“Entos” or the “Company”), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery...
Neurology

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

Newsemia
The Alzheimer’s Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy